Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Glossary Definition

A process regulated by the Food and Drug Administration (FDA) that allows manufacturers to provide investigational new drugs to patients with serious diseases or conditions who cannot participate in a clinical trial. One of several Study Types.

For more information on Expanded Access programs, visit the Expanded Access: Information for Patients page on the FDA Web site.